Efficacy and safety of Tumour necrosis factor inhibitors, Interleukin-17 inhibitors, and Janus kinase inhibitors in patients with non-radiographic axial spondyloarthritis: A systematic review and network meta-analysis

To systematically assess the efficacy and safety of tumour necrosis factor inhibitors (TNFi), interleukin-17 inhibitors (IL-17i) and Janus kinase inhibitors (JAKi) in patients with non-radiographic axial spondyloarthritis (nr-axSpA).